DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial In Q3 2024, DBV exceeded its recruitment goal and successfully closed the screening process for the VITESSE Phase 3 study ...
To inform regulatory policy, this article summarises findings on inhalation facilitation from the ninth report of the WHO Study Group on Tobacco Product Regulation. Some additives counteract the ...
More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet. The new study by the Global Research ...